Inify Laboratories Reports Growing NHS Interest in the UK
Inify Laboratories says interest from the UK’s NHS is growing. The available text also refers to data confirming diagnostic quality but provides no details.
Related stories
Polymarket Pauses Trading After $2.65 Million Exploit
Polymarket said it placed its exchange in cancel-only mode and paused relayer actions while investigating a compromise of a third-party provider. More than $2.6 million was lost wi
M impact | EQUITY | Oct 29, 2026, 07:01 PM UTC
A. O. Smith Reports Third-Quarter 2026 Revenue of $940.5 Million
Revenue fell 0.2% year over year to $940.5 million. Net income declined 4.3% to $126.3 million, while diluted EPS was $0.93 versus $0.94 a year earlier.
M impact | EQUITY | Oct 29, 2026, 07:01 PM UTC
Carrier Reports $2.59 Billion Third-Quarter Loss on $3.1 Billion Impairment
Carrier Global reported third-quarter 2026 revenue of $6.26 billion, up 12.3% year over year, and diluted EPS loss of $3.16. A $3.1 billion goodwill impairment was tied to weaker E
M impact | EQUITY | Oct 29, 2026, 07:01 PM UTC
Microsoft Plans Bond Sale to Fund AI Buildout
Microsoft said it is issuing debt in 10 parts, according to a filing.
M impact | EQUITY | Oct 29, 2026, 07:00 PM UTC
US session market picture: S&P 500 -0.62%, Nasdaq 100 -1.7%; EUR/USD +0.06%, WTI -0.64%, WBD leads volume
US session market picture. US index futures: S and P futures is down 0.62 percent, Nasdaq futures is down 1.7 percent, Dow futures is down 0.61 percent and Russell futures is up 0.
M impact | EQUITY | Oct 29, 2026, 07:00 PM UTC
Mexedia Signs Equity Investment Agreement for Up to EUR 20 Million
Mexedia signed a fixed-price equity investment agreement with Likan AG for up to EUR 20 million.
M impact | EQUITY | Oct 29, 2026, 07:00 PM UTC